Friday 24th October 2008

SESSION 9:
PARTICLE DELIVERY & PARTICLE BASED VACCINES
Moderator: Ed Lavelle (Trinity College Dublin, Ireland)

08.30-09.00
‘Stealth Microparticles™: A pathogen-mimicking microparticle technology for mucosal vaccine delivery with no cold chain requirements’
Susan Szathmary and Laszlo Stipkovits (GalenBio Inc., San Diego, California, USA)

09.00-09.30
‘Elicitation of protective immune responses against influenza following intranasal immunization with virus-like particles’
Kirsten Schneider, Ted M. Ross, Corey J. Crevar, Donald M. Carter, Brendan M. Giles and Rick A. Bright (University of Pittsburgh, Pittsburgh, Pennsylvania, USA)

09.30-09.50
‘New approach on the development of a mucosal maccine using biodegradable polymeric nanoparticles’
Helena F. Florindo, Sreenivas Pandit, Lidia Goncalves, Oya Alpar and Antonio J. Almeida (University of Lisbon, Portugal)

09.50-10.10
‘GEM particles as mucosal antigen delivery vehicle: Activation of the adult- and neonatal immune system and application in nasal vaccines’
Maarten van Roosmalen, Kees Leenhouts, Marcela Pasetti, Peter Hermans, Xavier Saelens and Hans Hektor (Mucosis BV, Groningen, The Netherlands)

10.10-10.30
‘An intranasal DNA vaccine for visceral leishmaniasis that is systemically expressed and improved with microparticles’
D.C.O. Gomes, E.F. Pinto, B.L.S. Costa, U.G. Lopes, M.I. Re and B. Rossi-Bergmann (Federal University of Rio de Janeiro, Brazil)

10.30-11.00
Coffee Break & Posters Breakdown

SESSION 10:
DELIVERY & LIVE VECTORS
Moderator: Ulf Schroder (Eurocine Vaccines AB, Sweden)

11.00-11.30
‘Enhancement of antigen-specific cellular immunity by mucosal targeting of microparticles with a novel lectin mimetic’
Ed Lavelle, E. McNeela, E. Lynch, and T. Leonard (Merrion Biopharmaceuticls Ltd. & Trinity College Dublin, Ireland)

11.30-11.50
‘Oral delivery of chimeric adenoviral vectors expressing TLR3 adjuvant and antigen protect ferrets against lethal avian flu’
Sean N. Tucker (Vaxart Inc., San Francisco, California, USA)

11.50-12.10
‘Live vaccines, vectors and production vessels: the next generation’
Marcel Thalen (Synco Bio Partners BV, Amsterdam, The Netherlands)

12.10-12.30
‘A replication-competent modified vaccinia Tian Tan is superior to modified vaccinia Ankara for inducing neutralizing antibodies via mucosal vaccination’
Zhiwei Chen, Xiaoxing Huang, Bin Lu, Qing Fang, Wenbo Yu, Li Liu, Po Tian, Ke Zhuang and Linqi Zhang (The University of Hong Kong, Hong Kong, China)

SESSION 11:
CLOSING PLENARY LECTURE
Moderator: Pearay L. Ogra (Buffalo, New York, USA)

12.30-13.00
‘Protection against common respiratory pathogens in early infancy: risks and opportunities’
Patrick Holt (University of Western Australia, Australia)

Conference Close, Lunch & Departure